- Home
- COF vs BSX Comparison
COF vs BSX Comparison
Compare COF & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COF
- BSX
- Stock Information
- Founded
- COF 1988
- BSX 1979
- Country
- COF United States
- BSX United States
- Employees
- COF N/A
- BSX N/A
- Industry
- COF Major Banks
- BSX Medical/Dental Instruments
- Sector
- COF Finance
- BSX Health Care
- Exchange
- COF Nasdaq
- BSX Nasdaq
- Market Cap
- COF 137.8B
- BSX 146.2B
- IPO Year
- COF 1994
- BSX 1992
- Fundamental
- Price
- COF $201.88
- BSX $97.16
- Analyst Decision
- COF Strong Buy
- BSX Strong Buy
- Analyst Count
- COF 17
- BSX 19
- Target Price
- COF $248.29
- BSX $124.53
- AVG Volume (30 Days)
- COF 3.6M
- BSX 7.9M
- Earning Date
- COF 10-21-2025
- BSX 10-22-2025
- Dividend Yield
- COF 1.19%
- BSX N/A
- EPS Growth
- COF N/A
- BSX 54.68
- EPS
- COF 2.38
- BSX 1.87
- Revenue
- COF $28,886,000,000.00
- BSX $19,349,000,000.00
- Revenue This Year
- COF $96.76
- BSX $21.04
- Revenue Next Year
- COF $18.34
- BSX $11.45
- P/E Ratio
- COF $85.02
- BSX $51.88
- Revenue Growth
- COF 9.02
- BSX 21.61
- 52 Week Low
- COF $143.22
- BSX $85.98
- 52 Week High
- COF $232.45
- BSX $109.50
- Technical
- Relative Strength Index (RSI)
- COF 33.59
- BSX 39.63
- Support Level
- COF $199.09
- BSX $97.45
- Resistance Level
- COF $223.57
- BSX $105.65
- Average True Range (ATR)
- COF 5.46
- BSX 2.02
- MACD
- COF -2.30
- BSX -0.29
- Stochastic Oscillator
- COF 11.76
- BSX 11.12
About COF Capital One Financial Corporation
Capital One is a diversified financial services holding company headquartered in McLean, Virginia. Originally a spinoff of Signet Financial's credit card division in 1994, the company is now primarily involved in credit card lending, auto loans, and commercial lending. Following the acquisition of Discover in 2025, the firm also has a modest personal loan business, though credit card lending still provides the majority of the bank's revenue.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.